A new anti-ErbB2 strategy in the treatment of cancer: Prevention of ligand-dependent ErbB2 receptor heterodimerization

Jose Baselga

Research output: Contribution to journalReview articleResearchpeer-review

39 Citations (Scopus)

Fingerprint Dive into the research topics of 'A new anti-ErbB2 strategy in the treatment of cancer: Prevention of ligand-dependent ErbB2 receptor heterodimerization'. Together they form a unique fingerprint.

Medicine & Life Sciences